The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 09, 2019

Filed:

Dec. 20, 2017
Applicant:

Soligenix, Inc., Princeton, NJ (US);

Inventors:

Oreola Donini, Coquitlam, CA;

Annett Rozek, Port Moody, CA;

Jackson Lee, Richmond, CA;

John North, Comox, CA;

Michael Abrams, Custer, WA (US);

Assignee:

Soligenix, Inc., Princeton, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 9/00 (2006.01); C07K 7/06 (2006.01); C07K 5/11 (2006.01); A61K 31/573 (2006.01); A61K 38/08 (2019.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 31/573 (2013.01); A61K 38/08 (2013.01); A61K 45/06 (2013.01); C07K 5/1019 (2013.01);
Abstract

Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis 'window' with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.


Find Patent Forward Citations

Loading…